View in EDS HTML Full Text

Viamet and Mycoses Study Group Education & Research Consortium Establish Collaboration to Advance a Novel Therapy for Cryptococcal Meningitis

Saved in:
Bibliographic Details
Title: Viamet and Mycoses Study Group Education & Research Consortium Establish Collaboration to Advance a Novel Therapy for Cryptococcal Meningitis
Authors: Viamet Pharmaceuticals, Inc. and Mycoses Study Group Education & Research Consortium
Source: Business Wire (English). 08/26/2015.
Abstract: Viamet Pharmaceuticals, Inc. and the Mycoses Study Group Education & Research Consortium (MSGERC) today announced the establishment of a strategic collaboration to advance a novel therapy for cryptococcal meningitis and other life-threatening fungal infections. This collaboration will combine the antifungal drug discovery and development expertise of Viamet with the strategic clinical development expertise of the MSGERC. [ABSTRACT FROM PUBLISHER]
Database: Regional Business News
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: bwh
DbLabel: Regional Business News
An: bizwire.c63771943
AccessLevel: 6
PubType: News
PubTypeId: newspaperArticle
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Viamet and Mycoses Study Group Education & Research Consortium Establish Collaboration to Advance a Novel Therapy for Cryptococcal Meningitis
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Viamet+Pharmaceuticals%2C+Inc%2E+and+Mycoses+Study+Group+Education+%26+Research+Consortium%22">Viamet Pharmaceuticals, Inc. and Mycoses Study Group Education & Research Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Business+Wire+%28English%29%22">Business Wire (English)</searchLink>. 08/26/2015.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Viamet Pharmaceuticals, Inc. and the Mycoses Study Group Education & Research Consortium (MSGERC) today announced the establishment of a strategic collaboration to advance a novel therapy for cryptococcal meningitis and other life-threatening fungal infections. This collaboration will combine the antifungal drug discovery and development expertise of Viamet with the strategic clinical development expertise of the MSGERC. [ABSTRACT FROM PUBLISHER]
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bwh&AN=bizwire.c63771943
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Viamet and Mycoses Study Group Education & Research Consortium Establish Collaboration to Advance a Novel Therapy for Cryptococcal Meningitis
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Viamet Pharmaceuticals, Inc. and Mycoses Study Group Education & Research Consortium
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 08
              Text: 08/26/2015
              Type: published
              Y: 2015
          Titles:
            – TitleFull: Business Wire (English)
              Type: main
ResultId 1